Hims & Hers Health, Inc. (HIMS) short interest & options flow
NYSEHims & Hers Health reports Q3 results on November 9 with 24.1% of its free float sold short, a founder holding a Schedule 13D position, and a stock down 11.8% over the past month trading at $26. Short interest has been remarkably stable heading into the print. At 52.9 million shares, the short position has barely moved over the past 30 days, edging fractionally lower rather than…
HIMS short interest utilization hits 92.06%, matching 52-week peak as earnings loom.
- Market cap
- $6.07B
- Next earnings
- 9 Nov 2026
Key data as of 7 Nov 2026

HIMS news and analysis
RSSNo long-form analysis yet for HIMS. Pulse alerts and the live data picture are available on ORTEX.
Open HIMS on ORTEX →Want the live picture for HIMS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HIMS — free to start on ORTEX.
Sign up for free →Open HIMS on ORTEX